Skip to main content
Fachgebiete
Automobil + Motoren Bauwesen + Immobilien Business IT + Informatik Elektrotechnik + Elektronik Energie + Nachhaltigkeit Finance + Banking Management + Führung Marketing + Vertrieb Maschinenbau + Werkstoffe Versicherung + Risiko
DE
EN
Bücher
Zeitschriften
Themenseiten
Organisationspsychologie Projektmanagement Marketing Smart Manufacturing
Weitere Formate
Podcasts Webinare Technik Webinare Wirtschaft Kongresse Veranstaltungskalender Awards
Jetzt Einzelzugang starten
Zugang für Unternehmen
Referenzkunden
SLX-Digitalkonferenz: Zukunftswerkstatt 2024

Mehr Umsatz mit Top-Kontakten

Am 7. Mai erfahren Sie, wie Vertriebsteams Leadgenerierung, Leadnurturing und Leadstrategien effizient steuern können.
Erweiterte Suche
Anmelden
nach oben
Erschienen in:
Biomaterials Influencing Human Lives Kapitel lesen Erstes Kapitel lesen

2017 | OriginalPaper | Buchkapitel

11. Future Perspectives of Bioactive Glasses for the Clinical Applications

verfasst von : V. Kumar, G. Pickrell, S.G. Waldrop, N. Sriranganathan

Erschienen in: Bioactive Glasses

Verlag: Springer International Publishing

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Tissue engineering is continuously evolving as an exciting and multidisciplinary field aiming to develop biological substitutes to restore, replace, or regenerate defective tissues. Scaffolds, cells, and growth-stimulating signals are the basic components of tissue engineering. However, researchers often encounter an enormous variety of choices when selecting scaffolds for tissue engineering. Typically, glass, ceramics, or polymeric biomaterials are used for making scaffolds, which provide the structural support for cell attachment and subsequent tissue development.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Jetzt informieren
Vorheriges Kapitel Bulk Metallic GlassesBulk Metallic Glasses for Healthcare: State of the Art and Prospects for the Future
Literatur
Denrya I, Liisa T (2016) Kuhn design and characterization of calcium phosphate ceramic scaffolds for bone tissue engineering. Dent Mater 32:43–53
Bakry AS, Takahashid H, Otsukie M, Tagamie J (2014) Evaluation of new treatment for incipient enamel demineralization using 45S5 bioglass. Oper Dent Mater 30:314–320
Tulyaganova DU, Reddy AA, Siegelc R, Ionescud E, Riedeld R, Ferreira JMF (2015) Synthesis and in vitro bioactivity assessment of injectable bioglass_organic pastes for bone tissue repair. Ceram Int 41:9373–9382
Renghini C, Giuliani A, Mazzoni S, Brun F, Larsson E, Baino F et al (2013) Microstructural characterization and in vitro bioactivity of porous glass ceramic scaffolds for bone regeneration by synchrotron radiation X-ray microtomography. J Eur Ceram Soc 33:1553–1565
Rahaman MN et al (2014) Mater Sci Eng C 41:224–231
Larrañaga A, Diamanti E, Rubio E, Palomares T, Alonso-Varona A, Aldazabal P, Martin FJ, Sarasua JR (2014) A study of themechanical properties and cytocompatibility of lactide and caprolactone based scaffolds filled with inorganic bioactive particles. Mater Sci Eng C 42:451–460
Gentile P, Bellucci D, Sola A, Matt C, Cannillo V, Ciardelli G (2015) Composite scaffolds for controlled drug release: role of the polyurethane nanoparticles on the physical properties andcell behavior. J Mech Behav Biomater 44:53–60
Chan BP, Leong KW (2008) Scaffolding in tissue engineering: general approaches and tissue-specific considerations. Eur Spine J 17(4):467–479
Bellucci D, Cannillo V, Sola A (2011a) Calcium and potassium addition to facilitate the sintering of bioactive glasses. Mater Lett 65:1825–1827
Bellucci D, Sola A, Cannillo V, (2012b) Low temperature sintering of innovative bioactive glasses. J Am Ceram Soc 95:1313–1319
Bellucci D, Sola A, Cannillo V (2013a) Bioactive glass-based composites for the production of dense sintered bodies and porous scaffolds. Mater Sci Eng C Mater Biol Appl 33:2138–2151
Idowu B, Cama G, Deb S, DiSilvio L (2014) In vitro osteoinductive potential of porous monetite for bone tissue engineering. J Tissue Eng 5:1–14 (2041731414536572)
Blaker J, Maquet V, Jérome R, Boccaccini AR, Nazhat SN (2005) Mechanical properties of highly porous PDLLA/bioglass composite foams as scaffolds for bone tissue engineering. Acta Biomater 1:643–652
Soundrapandiana C, Mahatob A, Kundu B, Datta S, Sac B, Basu D (2014) Development and effect of different bioactive silicate glass scaffolds: invitro evaluation for use as a bone drug delivery system. J Mech Behav Biomater 40:1–1 2
Rosenqvist K, Airaksinen S, Vehkamäki M, Juppo AM (2014) Evaluating optimal combination of clodronate and bioactive glass for dental application. Int J Pharm 468:112–120
Bakry AS, Takahashi H, Otsuki M, Sadr A, Yamashita K, Tagami J (2011) CO2 laser improves 45S5 bioglass interaction withdentin. J Dent Res 90(2):246–250
Baino F, Brovarone CV (2014) Bioceramics in ophthalmology. Acta Biomater 10:3372–3397
Kinnunen I, Aitasalo K, Pollonen M, Varpula M (2000) Reconstruction of orbital fractures using bioactive glass. J Craniomaxollofac Surg 28:229–234
Peltola M, Kinnunen I, Aitasalo K (2008) Reconstruction of orbital wall defects with bioactive glass plates. J Oral Maxillofac Surg 66:639–646
Chirila TV (2001) An overview of the development of artificial corneas with porous skirts and the use of PHEMA for such an application. Biomaterials 22:3311–3317
Linnola RJ, Happonen RP, Andersson OH, Vedel EA, Yli-Urpo U, Krause U et al (1996) Titanium and bioactive glass-ceramic coated titanium as materials for keratoprosthesis. Exp Eye Res 63:471–478
Tulyaganov DU, Agathopoulos S, Valerio P, Balamurugan A, Saranti A, Karakassides MA, Ferreira JM (2011) Synthesis, bioactivity and preliminary biocompatibility studies of glasses in the system CaO–MgO–SiO2–Na2O–P2O5–CaF2. J Mater Sci Mater Med 22:217–227
Tulyaganov DU, Makhkamov ME, Urazbaev A, Goel A, Ferreira JMF (2013) Synthesis, processing and characterization of a bioactive glass composition for bone regeneration. Ceram Int 39:2519–2526
Arcos D, Regí MV (2010) Sol–gel silica-based biomaterials and bone tissue regeneration. Acta Biomater 6:2874–2888
Bellantone M, Coleman NJ, Hench LL (2000) Bacteriostatic action of a novel four component bioactive glass. J Biomed Mater Res 51:484–490
Rezwan K, Chen QZ, Blaker J, Boccaccini AR (2006) Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 27:3413–3431
Fu Q, Saiz E, Rahaman MN, Tomsia AP (2011) Bioactive glass scaffolds for bone tissue engineering: state of the art and future perspectives. Mater Sci Eng C 31:1245–1256
Blaker J, Maquet V, Jérome R, Boccaccini AR, Nazhat SN (2005) Mechanical properties of highly porous PDLLA/bioglass composite foams as scaffolds for bone tissue engineering. Acta Biomater 1:643–652
Thomson RC, Yaszemski MJ, Power JM, Mikos AG (1998) Hydroxyapatite fiber reinforced poly(α-hydroxy ester) foams for bone regeneration. Biomaterials 19:1935–1943
Roether JA, Boccaccini AR, Hench LL, Maquet V, Gautier S, Jérome R (2002) Development and in vitro characterization of novel bioresorbable and bioactive composite materials based on polylactide foams and bioglassfor tissue engineering applications. Biomaterials 23:3871–3878
Maquet V, Boccaccini AR, Pravata L, Notingher I, Jérome R (2004) Porous poly (α-hydroxyacid)/bioglass composite scaffolds for bone tissue engineering I: preparation and in vitro characterization. Biomaterials 25:4185–4194
Chen JP, Chang YS (2011) Preparation and characterization of composite nanofibers of polycaprolactone and nanohydroxyapatite for osteogenic differentiationof mesenchymal stem cells. Colloids Surf B: Biointerfaces 86:169–175
Kim SS, Park MS, Jeon O, Choi CY, Kim BS (2006) Poly(lactide-co-glycolide)/hydroxyapatite composite scaffolds for bone tissue engineering. Biomaterials 27:1399–1409
Kim HW, Lee HH, Chun GS (2008) Bioactivity and osteoblast responses of novel biomedical nanocomposites of bioactive glass nanofiber filled poly(lactic acid) J Biomed Mater Res Part A 85:651–663
Gerhardt LC, Boccaccini AR (2010) Bioactive glass and glass-ceramic scaffolds for bone tissue engineering. Materials 3:3867–3910
Rahaman MN, Day DE, Bal BS, Fu Q, Jung SB, Bonewald LF, Tomsia AP (2011) Bioactive glass in tissue engineering. Acta Biomater 7:2355–2373
Lee J, Guarino V, Gloria A, Ambrosio L, Tae G, Kim et al YH (2010) Regeneration of Achilles’ tendon: the role of dynamic stimulation for enhanced cell proliferation and mechanical properties. J Biomater Sci 21:1173–1190
Jeong SI, Kim SH, Kim YH, Jung Y, Kwon JH, Kim et al BS (2004) Manufacture of elastic biodegradable PLCL scaffolds for mechano-active vascular tissue engineering. J Biomater Sci Polym Ed 15:645–660
Calori GM, Mazza E, Colombo M, Ripamonti C (2011) The use of bone-graft substitutes in large bone defects: any specific needs? Injury—Int J Care Inj 42:56–63
Albrektsson T, Johansson C. Osteoinduction (2001) Osteoconduction and osseointegration. Eur Spine J 10:96–101
Minardi S, Corradetti B, Taraballi F et al (2015) Evaluation of the osteoinductive potential of a bio-inspired scaffold mimicking the osteogenic niche for bone augmentation. Biomaterials 62:128–137
Wang L, Zhang B, Bao C et al (2014) Ectopic osteoid and bone formation by three calcium-phosphate ceramics in rats, rabbits and dogs. PLoS One 9(9):e107044
Daculsi G, Fellah BH, Miramond T (2014) The essential role of calcium phosphate bioceramics in bone regeneration. In: BenNissan B (ed), Advances in calcium phosphate biomaterials, Springer-Verlag, Berlin, pp 71–96
Landi E, Logroscino G, Proietti L et al (2008) Biomimetic Mg-substituted hydroxyapatite: from synthesis to in vivo behaviour. J Mater Sci Mater Med 19(1):239–247
Maier JAM, Bernardini D, Rayssiguier Y, Mazur A (2004) High concentrations of magnesium modulate vascular endothelial cell behaviour in vitro. Biochim Biophys Acta—Mol Basis Dis 1689(1):6–12
Marie PJ, Ammann P, Boivin G, Rey C (2001) Mechanisms of action and therapeutic potential of strontium in bone. Calcif Tissue Int 69(3):121–129
Marquis P, Roux C, Diaz-Curiel M et al (2007) Long-term beneficial effects of strontium ranelate on the quality of life in patients with vertebral osteoporosis (Soti study). Calcif Tissue Int 80:137–138
Ortolani S, Vai S (2006) Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages. Bone 38(2):19–22
Pors Nielsen S (2004) The biological role of strontium. Bone 35(3):583–588
Li H, Chang J (2013) Bioactive silicate materials stimulate angiogenesis in fibroblast and endothelial cell co-culture system through paracrine effect. Acta Biomater 9(6):6981–6991
Pietak AM, Reid JW, Stott MJ, Sayer M (2007) Silicon substitution in the calcium phosphate bioceramics. Biomaterials 28(28):4023–4032
Schwartzwalder K, Somers AV (1963) Inventors. General motors corporation, assignee. Method of making porous ceramic articles. US patent 3,090,094
Chang BS, Lee CK, Hong KS et al (2000) Osteoconduction at porous hydroxyapatite with various pore configurations. Biomaterials 21(12):1291–1298
Saiz E, Gremillard L, Menendez G et al (2007) Preparation of porous hydroxyapatite scaffolds. Mater Sci Eng C-Biomim Supramol Syst 27(3):546–550
Tian JT, Tian JM (2001) Preparation of porous hydroxyapatite. J Mater Sci 36(12):3061–3066
Padilla S, Sanchez-Salcedo S, Vallet-Regi M (2007) Bioactive glass as precursor of designed-architecture scaffolds for tissue engineering. J Biomed Mater Res Part A 81(1):224–232
Santos JD, Knowles JC, Reis RL, Monteiro FJ, Hastings GW (1994) Microstructural characterization of glass-reinforced hydroxyapatite composites. Biomaterials 15(1):5–10
Colombo P, Hellmann JR (2002) Ceramic foams from preceramic polymers. Mater Res Innov 6(5–6):260–272
Shepherd JH, Best SM (2011) Calcium phosphate scaffolds for bone repair. JOM 63(4):83–92
Lewis JA, Smay JE (2005) Three-dimensional periodic structures. Cell Ceram Struct Manuf Properties Appl pp 87–100
Lewis JA, Smay JE, Stuecker J, Cesarano III J (2006) Direct ink writing of three-dimensional ceramic structures. J Am Ceram Soc 89(12):3599–3609
Simon JL, Michna S, Lewis JA et al (2007) In vivo bone response to 3D periodic hydroxyapatite scaffolds assembled by direct ink writing. J Biomed Mater Res Part A 83(3):747–758
Hutmacher DW (2000) Scaffolds in tissue engineering bone and cartilage. Biomaterials 21(24):2529–2543
Descamps M, Duhoo T, Monchau F et al (2008) Manufacture of macroporous beta-tricalcium phosphate bioceramics. J Eur Ceram Soc 28(1):149–157
Descamps M, Richart O, Hardouin P, Hornez JC, Leriche A (2008) Synthesis of macroporous beta-tricalcium phosphate with controlled porous architectural. Ceram Int 34(5):1131–1137
Michna S, Wu W, Lewis JA (2005) Concentrated hydroxyapatite inks for direct-write assembly of 3-D periodic scaffolds. Biomaterials 26(28):5632–5639
Denry I, Holloway JA (2014) Low temperature sintering of fluorapatite glass-ceramics. Dental Mater 30(2):112–121
Fu Q, Saiz E, Rahaman MN, Tomsia AP (2011) Bioactive glass scaffolds for bone tissue engineering: state of the art and future perspectives. Mater Sci Eng C—Mater Biol Appl 31(7):1245–1256
Barrere F, Mahmood TA, de Groot K, van Blitterswijk CA (2008) Advanced biomaterials for skeletal tissue regeneration: Instructive and smart functions. Mater Sci Eng R Rep 59(1–6):38–71
Barrere F, van Blitterswijk CA, de Groot K (2006) Bone regeneration: molecular and cellular interactions with calcium phosphate ceramics. Int J Nanomed 1(3):317–332
Davies JE (2007) Bone bonding at natural and biomaterial surfaces. Biomaterials 28(34):5058–5067
Woodard JR, Hilldore AJ, Lan SK et al (2007) The mechanical properties and osteoconductivity of hydroxyapatite bone scaffolds with multi-scale porosity. Biomaterials 28(1):45–54
Diaz-Rodriguez P, Gonzalez P, Serra J, Landin M (2014) Key parameters in blood-surface interactions of 3D bioinspired ceramic materials. Mater Sci Eng C-Mater Biol Appl 41:232–239
Seyfert UT, Biehl V, Schenk J (2002) In vitro hemocompatibility testing of biomaterials according to the ISO 10993–4. Biomol Eng 19(2–6):91–96
ISO (2002) Standard 10993-4 Biological evaluation of medical devices—part 4: selection of tests for interactions with blood
LeGeros RZ (2002) Properties of osteoconductive biomaterials: calcium phosphates. Clin Orthop Relat Res 395:81–98
Autefage H, Briand-Mesange F, Cazalbou S et al (2009) Adsorption and release of BMP-2 on nanocrystalline apatite-coated and uncoated hydroxyapatite/beta-tricalcium phosphate porous ceramics. J Biomed Mater Res B Appl Biomater 91(2):706–715
Liu Y, de Groot K, Hunziker EB (2005) BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model. Bone 36(5):745–757
Roldan JC, Detsch R, Schaefer S et al (2010) Bone formation and degradation of a highly porous biphasic calcium phosphate ceramic in presence of BMP-7, VEGF and mesenchymal stem cells in an ectopic mouse model. J Craniomaxillofac Surg 38(6):423–430
Guicheux J, Gauthier O, Aguado E et al (1998) Human growth hormone locally released in bone sites by calcium-phosphate biomaterial stimulates ceramic bone substitution without systemic effects: a rabbit study. J Bone Miner Res 13(4):739–748
Thomson RC, Yaszemski MJ, Power JM, Mikos AG (1998) Hydroxyapatite fiber reinforced poly(α-hydroxy ester) foams for bone regeneration. Biomaterials 19:1935–1943.
Lee J, Guarino V, Gloria A, Ambrosio L, Tae G, Kim YH (2010) Regeneration of Achilles’ tendon: the role of dynamic stimulation for enhanced cell proliferation and mechanical properties. J Biomater Sci 21:1173–1190
Jeong SI, Kim SH, Kim YH, Jung Y, Kwon JH, Kim BS et al (2004) Manufacture of elastic biodegradable PLCL scaffolds for mechano-active vascular tissue engineering. J Biomater Sci Polym Ed 15:645–660
Yunos DM, Bretcanu O, Boccaccini A (2008) Polymer–bioceramic composites for tissue engineering scaffolds. J Mater Sci Mater Med 43:4433–4442
Yagmurlu MF, Korkusuz F, Guersel I, Korkusuz P, Ors U, Hasirci V (1999) Sulbactam-cefoperazone polyhydroxybutyrate-co-hydroxyvalerate (PHBV) local antibiotic delivery system: in vivo effectiveness and biocompatibility in the treatment of implant-related experimental osteomyelitis. J Biomed Mater Res 46:494–503
Zhang X, Wyss UP, Pichora D, GoosenMF (1994a) Biodegradable controlled antibiotic release devices for osteomyelitis: optimization of release properties.J Pharm Pharmacol 46:718–724
Zhang X, Wyss UP, Pichora D, Goosen MFA (1994b) Amechanistic study of antibiotic release from biodegradable poly (d, 1-lactide)cylinders. J Control Release 31:129–144
Domingues ZR, Cortés, ME, Gomes TA, Diniz HF, Freitas CS, Gomes JB, Faria AMC, Sinisterra RD (2004) Bioactive glass as a drug delivery system of tetracycline and tetracycline associated with β-cyclodextrin. Biomaterials 25:327–333
Czarnobaj K (2008) Preparation and characterization of silica xerogels as carriers for drugs. Drug Deliv 15:485–492
Merchant HA, Shoaib HM, Tazeen J, Yousuf RI (2006) Once- daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: a technical note. AAPS PharmSciTech 7:78
Bang H-G, Kim S-J, Park S-Y (2008) Biocompatibilityandthe physicalpropertiesofbio-glassceramicsinthe Na2O–CaO–SiO2–P2O5 system withCaF2 and MgF2 additives. J Ceram Proc Res 9:588–590
Aina V, Malavasi G, Fiorio Pla A, Munaron L, Morterra C (2009) Zinc-containing bioactive glasses: surface reactivity and behaviour towards endothelial cells. Acta Biomater 5:1211–1222
Ma ZJ, Yamaguchi M (2001) Role of endogenous zinc in the enhancement of bone protein synthesis associated with bone growth of newborn rats. J Bone Miner Metab 19:38–44
Xia W, Chang J (2006) Well-ordered mesoporous bioactive glasses (MBG): a promising bioactive drug delivery system. J Control Release 110:522–530
Kundu B, Soundrapandian C, Nandi SK, Mukherjee P, Dandapat N, Roy S, Datta BK, Mandal TK, Basu D, Bhattacharya RN (2010b) Development of new localized drug delivery system based on ceftriaxone-sulbactam composite drug impregnated porous hydroxyapatite: a systematic approach for in vitro and in vivo animal trial. Pharm Res 27:1659–1676.
Noble L, Gray AI, Sadiq L, Uchegbu IF (1999) A non-covalently cross-linked chitosan based hydrogel. Int J Pharm 192:173–182
Rossi S, Marciello M, Sandri G, Bonferoni MC, Ferrari F, Caramella C (2008) Chitosan ascorbate: a chitosan salt with improved penetration enhancement properties. Pharm Dev Technol 13:513–521
Ubaidulla U, Khar RK, Ahmad FJ, Tripathi P (2009) Optimization of chitosan succinate and chitosan phthalate microspheres for oral delivery of insulin using response surface methodology. Pharm Dev Technol 14:96–105
Baldrick P (2010) The safety of chitosan as a pharmaceutical excipient. Regul Toxicol Pharmacol 56:290–299
Kong M, Chen XG, Liu CS, Liu CG, Meng XH, Yu le J (2008) Antibacterial mechanism of chitosan microspheres in a solid dispersing system against E. coli. Colloids Surf 65:197–202
Park Y, Kim MH, Park SC, Cheong H, Jang MK, Nah JW, Hahm KS (2008) Investigation of the anti fungal activity and mechanism of action of LMWS-chitosan. J Microbiol Biotechnol 18:1729–1734
Rosenqvist K, Airaksinen S, Fraser SJ, Gordon KC, Juppo AM (2013) Interaction of bioactive glass with clodronate. Int J Pharm 452:102–107
Cross KJ, Huq NL, Stanton DP, Sum M, Reynolds EC (2004) NMR studies of a novel calcium, phosphate and fluoride delivery vehicle-alpha(S1)-casein(59-79) by stabilized amorphous calcium fluoride phosphate nanocomplexes. Biomaterials 25(20):5061–5069
Borges BC, de Souza Borges J, de Araujo LS, Machado CT, DosSantos AJ, de Assuncao Pinheiro IV (2011) Update on nonsurgical, ultraconservative approaches to treat effectivelynon-cavitated caries lesions in permanent teeth. Eur J Dent 5(2):229–236
Fan Y, Sun Z, Moradian-Oldak J (2009) Controlled remineralizationof enamel in the presence of amelogenin and fluoride. Biomaterials 30(4):478–483
Nganga S, Zhang D, Moritz N, Vallittu PK, Hupa L (2012) Multi-layerporous fiber-reinforced composites for implants: in vitrocalcium phosphate formation in the presence of bioactiveglass. Dent Mater 28(11):1134–1145
Hench LL (1991) Bioceramics—from concept to clinic. J Am Ceram Soc 74(7):1487–1510
Bunker BC, Tallant DR, Headley TJ, Turner GL, Kirkpatrick RJ (1988) The structure of leached sodium borosilicate glass. Phys Chem Glasses 29(3):106–120
Hench LL, Splinter RJ, Allen WC, Greenlee TK (1972) Bonding mechanisms at the interface of ceramic prosthetic materials. J Biomed Mater Res 2:117–141
Aitasalo K, Kinnunen I, Palmgren J, Varpula M (2001) Repair of orbital floor fractures with bioactive glass implants. J Oral Maxillofac Surg 59:1390–1396
Tesavibul P, Felzmann R, Gruber S, Liska R, Thompson I, Boccaccini AR et al (2012) Processing of 45S5 Bioglass—by lithography-based additive manufacturing. Mater Lett 74:81–84
Vitale-Brovarone C, Baino F, Verné E (2009) High strength bioactive glass-ceramic scaffolds for bone regeneration. J Mater Sci Mater Med 20:643–653
Izquierdo-Barba I, Salinas AJ, Vallet-Regí M (2013) Bioactive glasses: from macro tonano. Int J Appl Glass Sci 4:149–161
Merceron C, Vinatier C, Clouet J, Colliec-Jouault S, Weiss P, Guicheux J (2008) Adipose-derived mesenchymal stem cells and biomaterials for cartilage tissue engineering. Joint Bone Spine. Rev Rhum 75:672–674
Schneider OD, Weber F, Brunner TJ, Loher S, Ehrbar M, Schmidlin PR, Stark WJ (2009) Invivo and in vitro evaluation of flexible, cottonwool-like nano composites as bone substitute material for complex defects. Acta Biomater 5:1775–1784
Weiss P, Layrolle P, Clergeau LP, Enckel B, Pilet P, Amouriq Y, Daculsi G, Giumelli B (2007) The safety and efficacy of an injectable bone substitute in dental sockets demonstrated in a human clinical trial. Biomaterials 28:3295–3305
Williams DF (2008) On the mechanisms of biocompatibility. Biomaterials 29:2941–2953
Ducheyne P (2011) Biomaterials. In: Ducheyne P (ed), Comprehensive biomaterials, Elsevier, Oxford, pp 1–4
Hench LL, Day DE, Höland W, Rheinberger VM (2010) Glassand medicine. Int J Appl Glass Sci 1:104–117
Hoppe A, Guldal NS, Boccaccini AR (2011) A review of the biological response toionic dissolution products from bioactive glasses and glass–ceramics. Biomaterials 32:2757–2774
Xynos ID, Edgar AJ, Lee DK, Larry B, Hench L, Polak JM (2001) Gene-expression profiling of human osteoblasts following treatment with the ionic productsof Bioglass 45S5 dissolution. J Biomed Mater Res 55:151–157
Hench LL (1994) Bioactive ceramics: theory and clinical applications, Oxford
Agathopoulos S, Tulyaganov DU, Valerio P, Ferreira JM (200) A new model formulation of the SiO2–Al2O3–B2O3–MgO–CaO–Na2O–F glass–ceramics. Biomaterials 26:2255–2264
Kansal I, Tulyaganov DU, Goel A, Pascual MJ, Ferreira JMF(2010) Structural analysis and thermal behavior of diopside–fluorapatite–wollas-tonite-based glasses and glass–ceramics. Acta Biomater 6:4380–4388
Tulyaganov DU, Agathopoulos S, Ventura JM, Karakassides MA, Fabrichnaya O, Ferreira JMF (2006) Synthesis of glass–ceramics in the CaO–MgO–SiO2 system with B2O3, P2O5, Na2O and CaF2 additives. J Eur Ceram Soc 26:1463–1471
Agathopoulos S, Tulyaganov DU, Ventura JMG, Kannan S, Saranti A, Karakassides MA, Ferreira JMF (2006) Structural analysis and devitrification of glasses based on the CaO–MgO–SiO2 system with B2O3, Na2O, CaF2 and P2O5 additives. J Non Cryst Solids 352:322–328
Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR (2006) Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 27:3413–3431
Saboori A, Rabiee M, Mutarzadeh F, Sheikhi M, Tahriri M, Karimi M (2009) Synthesis, characterizations and in vitro bioactivity of sol–gel-derived SiO2–CaO–P2O5–MgO bioglass. Mater Sci Eng C 29:335–340
Catauro M, Raucci MG, De Gaetano F, Marotta A (2004) Antibacterial and bioactive silver-containing Na2O–CaO–2SiO2 glass prepared by sol–gel method. J Mater Sci Mater Med 15:831–837
Ragel CV, Vallet-Regí M (2000) In vitro bioactivity and gentamicin release from glass–polymer-antibiotic composites. J Biomed Mater Res 51:424–429
Arcos D, Ragel CV, Vallet-Regi M (2001) Bioactivity in glass/PMMA composites used as drug delivery system. Biomaterials 22:701–708
Ladrón de Guevara S, Ragel CV, Vallet-Regí M (2003) Bioactive glass–polymer materials for controlled release of ibuprofen. Biomaterials 24:4037–4043
Arcos D, Peña J, Vallet-Regí M (2003) Influence of a SiO2–CaO–P2O5 sol–gel on the bioactivity and controlled release of a ceramic/polymer/antibiotic mixed materials. Chem Mater 15:4132–4138
Arcos D, del Real RP, Vallet-Regí M (2002) A novel bioactive and magnetic biphasic material. Biomaterials 23:2151–2158
Ruiz E, Serrano MC, Arcos D, Vallet-Regí M (2006) Glass–glass ceramic thermoseeds for hyperthermic treatment of bone tumours. J Biomed Mater Res 79:533–543
Serrano MC, Portoles MT, Pagani R, Sáez de Guinoa J, Ruíz-Fernández E, Arcos D et al (2008) In vitro positive biocompatibility evaluation of glass–glass ceramic thermoseeds for hyperthermic treatment of bone tumours. Tissue Eng 14:617–627
Ragel CV, Vallet-Regí M, Rodríguez-Lorenzo LM (2002) Preparation and in vitro bioactivity of hydroxyapatite/solgel-glass biphasic material. Biomaterials 23:1865–1872
Vallet-Regí M, Rámila A, Padilla S, Muñoz B (2003) Bioactive glasses as accelerators of the apatites bioactivity. J Biomed Mater Res 66:580–585
Campostrini R, Carturam G (1996) Immobilisation of plant cells in hybrid sol–gel material. J Sol-Gel Sci Technol 7:87–97
Pope Edgard JA (1997) Bioartificial organs I: silica gel encapsulated pancreatic islets for the treatment of diabetes mellitus. J Sol-Gel Sci Technol 8:635–639
Vallet-Regí M (2006) Revisiting ceramics for medical applications. Dalton Trans 44:5211–5220
Vallet-Regí M, Balas F, Arcos D (2007) Mesoporous materials for drug delivery. Angew Chem Int Ed 46:7548–7558
López-Noriega A, Arcos D, Izquierdo-Barba I, Sakamoto Y, Terasaki O, Vallet- Regí M (2006) Ordered mesoporous bioactive glasses for bone tissue regeneration. Chem Mater 18:3137–3144
Izquierdo-Barba I, Arcos D, Sakamoto Y, Terasaki O, López-Noriega A, Vallet- Regí M (2008) High-performance mesoporous bioceramics mimicking bone mineralization. Chem Mater 20:3191–3198
Leonova E, Izquierdo-Barba I, Arcos D, López-Noriega A, Hedi N, Vallet-Regí M et al (2008) Multinuclear solid-state NMR studies of ordered mesoporous bioactive glasses. J Phys Chem C 112:5552–5562
Garcia A, Cicuendez M, Izquierdo-Barba I, Arcos D, Vallet-Regí M (2009) Essential role of calcium phosphate heterogeneities in 2D-hexagonal and 3D-cubic SiO2–CaO–P2O5 mesoporous bioactive glasses. Chem Mater 21:5474–5484
Donlan RM, Costerton JW (2002) Clin Microbiol Rev 15:167
Hanssen AD (2005) Clin Orthop Relat Res P 437
Brown RF, Rahaman MN, Dwilewicz AB, Huang W, Day DE, Li Y, Bal BS (2009) J Biomed Mater Res A 88:392
Zhang D, Munukka E, Hupa L, Ylänen HO, Viljanen MK, Hupa M (2007) Key Eng Mater 173:330–332
Fu Q, Huang W, Jia W, Rahaman MN, Liu X, Tomsia AP (2011) Tissue Eng A 17:3077
Kaur G, Pandey OP, Singh K, Homa D, Scott B, Pickrell G (2013) A review of bioactive glasses: their structure, properties, fabrication, and apatite formation. J Biomed Mater Res A 102:254–274
Kaur G, Sharma P, Kumar V, Singh K (2012) Assesment of in-vitro bioactivity of SiO2-BaO-ZnO-B2O3-Al2O3 glasses: an optico-analytical approach. Mater Sci Engg C 32(7):1941–1947
Kaur G, Pickrell G, Sriranganathan N, Kumar V, Homa D (2016) Review and the state of the art: Sol-gel or melt quenched bioactive glasses for tissue engineering. J Biomed Mater Res: B Appl Biomater 104(6):1248–1275. doi:10.​1002/​jbm.​b.​33443
Kaur G, Pickrell G, Pandey OP, Singh K, Chudasama BN, Kumar V (2016) Combined and individual Doxorubicin/Vancomycin drug loading, release kinetics and apatite formation for the CaO-CuO-P2O5- SiO2- B2O3 mesoporous glasses. RSC Adv 6:51046–51056
Kaur G, Pickrell G, Kimsawatde G, Allbee H, Sriranganathan N (2014) Synthesis, cytotoxicity, and hydroxypatite formation in 27-Tris-SBF for sol-gel based CaO-P2O5-SiO2-B2O3-ZnO bioactive glasses. Sci Rep. doi:10.​1038/​srep04392
Metadaten
Titel
Future Perspectives of Bioactive Glasses for the Clinical Applications
verfasst von
V. Kumar
G. Pickrell
S.G. Waldrop
N. Sriranganathan
Copyright-Jahr
2017
Buch
Bioactive Glasses

Print ISBN: 978-3-319-45715-4

Electronic ISBN: 978-3-319-45716-1

Copyright-Jahr: 2017

DOI
https://doi.org/10.1007/978-3-319-45716-1_11

Neuer Inhalt

    Bildnachweise